Title:
USE OF OVATODIOLIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF IN PREVENTION AND TREATMENT OF RENAL FIBROSIS
Document Type and Number:
WIPO Patent Application WO/2024/017310
Kind Code:
A1
Abstract:
The present invention relates to use of a compound represented by formula (I) or a pharmaceutically acceptable salt thereof in the preparation of a medicament for treating and/or preventing renal fibrosis and/or renal diseases related to renal fibrosis. The compound represented by formula (I) has a structure as follows:
More Like This:
| WO/2003/031441 | MULTIPLE ACTION COMPOUNDS |
| JP4220779 | Chemical compounds |
| WO/2014/177011 | DIMALEATE OF INDOLINONE DERIVATIVE, AND POLYMORPHS THEREOF |
Inventors:
LONG HAIBO (CN)
BAO SHIQI (CN)
BAO SHIQI (CN)
Application Number:
PCT/CN2023/108239
Publication Date:
January 25, 2024
Filing Date:
July 19, 2023
Export Citation:
Assignee:
ZHUJIANG HOSPITAL SOUTHERN MEDICAL UNIV (CN)
ACCENDATECH HEFEI BIOTECH CO LTD (CN)
ACCENDATECH HEFEI BIOTECH CO LTD (CN)
International Classes:
A61K31/496; A61P13/12
Domestic Patent References:
| WO2021236811A1 | 2021-11-25 | |||
| WO2021236808A1 | 2021-11-25 |
Foreign References:
| CN111303178A | 2020-06-19 | |||
| CN109796429A | 2019-05-24 |
Other References:
ZHANG YAN, YUE ZHANG: "The advances in research on the intervention of triptolide in kidney disease", CHINESE BULLETIN OF LIFE SCIENCES, vol. 24, no. 1, 15 January 2012 (2012-01-15), pages 69 - 73, XP093130234, DOI: 10.13376/j.cbls/2012.01.007
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: